Biocompatible Reactive Oxygen Species (ROS)‐Responsive Nanoparticles as Superior Drug Delivery Vehicles

Dinglin Zhang, Yanling Wei, Kai Chen, +8

Advanced Healthcare Materials

Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly

Qing Shi, Yasheng Zhu, Jian Ma, +18

Molecular Cancer

DIFFERENTIAL microRNA EXPRESSION IN CHILDHOOD B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Xiuli Ju, Dong Li, Qing Shi, +3

Pediatric Hematology and Oncology

Hematological MalignancyMirna ChipFunctional GenomicsMature MirnaMixed-phenotype Acute Leukemia +11

SPOP mutation induces DNA methylation via stabilizing GLP/G9a

Jianong Zhang, Kun Gao, Hongyan Xie, +19

Nature Communications

SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression

Jian Ma, Kun Chang, Jingtao Peng, +16

Journal of Experimental & Clinical Cancer Research

CRL3–SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the MyD88/NF-κB signaling

Xiaofeng Jin, Qing Shi, Qian Li, +28

Leukemia

Tumor BiologyLymphoid NeoplasiaCell RegulationMyd88/nf-κb SignalingImmune Cell Development +10

Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice

Yin Dou, Jiawei Guo, Yue Chen, +9

Journal of Controlled Release

NanomedicineEngineeringMedicineNano-drug DeliveryPharmacotherapy +3

ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation.

Jiantao Xiao, Qing Shi, Weiguo Li, +8

PubMed

Renal PathologyYap1 DegradationCancer BiologyTumor BiologyTranscriptional Regulation +18

SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1–PD-L1 axis

Kun Gao, Qing Shi, Ye Gu, +7

Cell Death and Differentiation

MedicineTumor ImmunityCancer GenomicsImmune SurveillanceSpop Mutations +7

Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells

Qing Shi, Lin Zhang, Mengyu Liu, +6

Biomaterials

NanomedicineNanotherapeuticsHealth SciencesPolymer-drug ConjugateMedicine +8